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a b s t r a c t
Feline immunodeﬁciencyvirus (FIV) causes a slowprogressivedegenerationof the immune systemwhich
eventually leads to a disease comparable to acquired immune deﬁciency syndrome (AIDS) in humans.
FIV has extensive sequence variation, a typical feature of lentiviruses. Sequence analysis showed that
diversity was not evenly distributed throughout the genome, but was greatest in the envelope gene,
env. The virus enters host cells via a sequential interaction, initiated by the envelope glycoprotein (env)
binding the primary receptor molecule CD134 and followed by a subsequent interaction with chemokine
co-receptor CXCR4. The purpose of this study was to isolate and characterize isolates of FIV from an open
shelter in São Paulo, Brazil. The separated PBMC from 11 positive cats were co-cultured with MYA-1eceptor cells. Full-length viral env glycoprotein genes were ampliﬁed and determined. Chimeric feline×human
CD134 receptors were used to investigate the receptor utilization of 17 clones from Brazilian isolates of
FIV. Analyses of the sequence present of molecular clones showed that all clones grouped within subtype
B. In contrast to the virulent primary isolate FIV-GL8, expression of the ﬁrst cysteine-rich domain (CRD1)
of felineCD134 in the context ofhumanCD134was sufﬁcient for optimal receptor function for all Brazilian
FIV isolates tested.
. Introduction
Feline immunodeﬁciency virus (FIV) is a widespread pathogen
f the domestic cat. Cats carrying the virus present with a vari-
ty of clinical signs, most notably chronic gingivostomatitis and
ymphadenopathy (Hosie et al., 1989; Yamamoto et al., 1989). FIV
s a member of the lentivirus genus of the Retroviridae family.
entiviruses like human immunodeﬁciency virus (HIV) and FIV
re notorious for their extensive genetic variation and for their
apid diversiﬁcationwithin a single host (Overbaugh andBangham,
001). In part, this diversiﬁcation is due to the virus having a rapid
ate of replication and a high error rate of reverse transcription
Mcgrath et al., 2001). FIV is unique amongst the non-primate
entiviruses as in its natural host, the domestic cat, it produces a
isease similar to AIDS. Since FIV, like human immunodeﬁciency
irus, has a long and variable disease course, it is often difﬁcult to
redict the outcome for an infected cat.
The FIV genome consists of three major genes and several
maller regulatory genes. Like other lentiviruses, FIV exhibits
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extensive genetic variation (Roberts et al., 1988; Kann et al., 2007).
The pol and gag genes encode viral enzymes and core proteins,
respectively, these genes are relatively highly conserved. The env
gene encodes surface and transmembrane glycoproteins and is
highly variable (Olmsted et al., 1989; Talbott et al., 1989; Greene
et al., 1993). Within the env gene, nine variable regions have
been deﬁned, separated by more conserved regions (Pancino et al.,
1993b). On the basis of analyses of env variable regions V3–V5,
FIV has been classiﬁed into ﬁve subtypes (A–E) and recombinant
strains (Sodora et al., 1994; Kakinuma et al., 1995; Pecoraro et al.,
1996) the number of subtypes may increase as further studies
reveal additional diversity. Recent studies identiﬁeddistinct groups
of FIV isolates from the Unites States and New Zealand (Weaver
et al., 2004; Hayward et al., 2007). The env region contains deter-
minants important for cell tropism, cytopathogenicity, infectivity
and prominent immunoreactive domains (Siebelink et al., 1992;
Lombardi et al., 1993; Pancino et al., 1993a).
The prevalence rates of FIV infection in Brazil has not been
evaluated extensively and regional variations are largely unex-
Open access under the Elsevier OA license.plored (Martins et al., 2008). Larger surveys of Brazilian isolates are
required to determine whether FIV isolates in Brazil have evolved
within a single subtype. Preliminary work has suggested that sub-
type B isolates are present in the domestic cat population of Brazil
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Caxito et al., 2006; Martins et al., 2008; Teixeira et al., 2010) but a
eﬁnitive identiﬁcation of circulating subtypes is essential in order
o develop strategies for molecular diagnosis, since the genetic
iversity amongst subtypes is high (Reggeti and Bienzle, 2004) and
ay lead to diagnostic problems.
Anumberof factors appear to inﬂuence theoutcomeof FIV infec-
ion. Progression of the disease follows a pattern similar to that
bservedwith primate lentiviruses; it beginswith a relatively short
cute phase deﬁned by an incremental increase in viral load, low-
rade fever, weight loss, lymphadenopathy and neutropenia. The
cute phase is followed by an asymptomatic period, which may be
rawn out for years. It is typiﬁed by antiviral immune responses,
ower viral titers, and a gradual decline in CD4+ cells, although few
linical signs are observed. Finally, the terminal phase is character-
zedbyan immunologicdecompensation, a rise inplasmaviral load,
nd clinical signs of immunodeﬁciency characterized by increased
usceptibility to opportunistic infections (English et al., 1994;Hosie
nd Beatty, 2007).
Although the principal hallmark of FIV infection is a decrease in
D4+ cells, the virus has also been shown to infect a variety of cell
ypes including CD4+ and CD8+ lymphocytes, B lymphocytes, cells
f neuronal lineage and a monocyte/macrophage lineage (English
t al., 1993; Dean et al., 1996; Joshi et al., 2005). Joshi et al. (2005)
escribed feline CD4+ CD25+ T regulatory (Treg) cells with the abil-
ty to support FIV replication. Recently a studyhas shown that feline
entritic cells (DCs) express speciﬁc viral receptors for FIV and can
e infected by the virus (Reggeti et al., 2008). The speciﬁcity of
he virus-receptors interaction is the earliest determinant of cell
ropism and a decisive factor in the pathogenesis of viral disease
Willett et al., 2006b). FIV is characterized by similar pattern of
eceptor usage to that of HIV-1; however, CD134 rather than CD4
s theprimary receptor, and the subsequent interactionwith the co-
eceptor CXCR4 permits cells entry (Shimojima et al., 2004). CD134
as originally identiﬁed as MRC OX-40, an antigen expressed on
ctivated rat CD4+ T cells which belongs to the tumor necrosis
actor receptor/nerve growth factor receptor (TNFR/NGFR) super-
amily (Paterson et al., 1987; Mallett et al., 1990). The SU of FIV,
p95, binds to activated cells expressing CD134, a 43-kDa recep-
or. Studies have indicated that FIV infection of certain cells may
esult solely through binding the co-receptor molecule CXCR4 pro-
iding the expression of the chemokine receptor is sufﬁciently high
De Parseval and Elder, 2001). Recent studies have revealed dif-
erential utilization of feline CD134 by FIV. Primary isolates of FIV
an be categorized into at least two groups on the basis of their
nteractions with CD134. The expression of the ﬁrst cysteine-rich
omain (CRD1) of feline CD134 alone is sufﬁcient to confer nearly
ptimal receptor function for infection with strains such as PPR,
ubtype A, and B2542 (subtype B), although pathogenic primary
trains of virus, such as GL8, subtype A, GPGammer (subtype C) and
CSU1 (subtype B) require additional determinantswithin the sec-
nd cysteine-rich domain, CRD2, of CD134 (Willett et al., 2006a,b).
irus tropism may be inﬂuenced by several factors, including the
fﬁnity of the viral envelope for the receptor, the level of expression
f the receptor molecules, the conformational heterogeneity of the
iral envelope and receptors, and/or the presence of attachment
ofactors such as heparin sulphate proteoglycans (HSPGs) and the
peciﬁc C-type lectin expressed in dendritic cells (DC-SIGN) (De
arseval et al., 2004a,b; Willett et al., 2010).
Considerable debate is ongoing about feral cat populations
Luria et al., 2004). These cats have long been an area of con-
ern in other countries, particularly European countries and in the
nited States, as evidenced by the frequency of disease prevalence
ata available. Issues of concern include the welfare of the cats
hemselves, public nuisances they may cause, their impact on the
nvironment, and their impact on both public health as well as
eline health.arch 160 (2011) 59–65
Thepurpose of this studywas to isolate and characterize isolates
of FIV from an open shelter in Sao Paulo, Brazil.
2. Materials and methods
2.1. Open shelter
Cats from an open shelter in São Paulo, Brazil, with reported
cases of FIV infection were tested in this study. Blood samples from
55 domestic, short haired cats were collected by jugular venipunc-
ture and placed in serum separator and EDTA treated glass tubes.
Serum and whole blood were stored at −80 ◦C until diagnostic test-
ing was performed. FIV infection in cats was determined using a
polymerase chain reaction (PCR)-based method to amplify the gag
gene (Hohdatsu et al., 1998) and the SNAP FIV/FeLV Comb Test,
IDEXXTM – Westbrook, EUA to detect antibody.
2.2. Cells and viruses
MYA-1 (Miyazawa et al., 1989) and cell lines derived from
the feline large granular lymphoma cell line, MCC cells (Cheney
et al., 1990), were cultured in RPMI 1640 medium. HEK-293T cells
were maintained in Dulbecco’s modiﬁcation of Eagle’s medium.
All media were supplemented with 10% fetal bovine serum, 2mM
glutamine, 0.11mg/mL sodium pyruvate, 100 IU/mL penicillin, and
100g/mL streptomycin. In addition the medium for MYA-1 cells
was supplemented with 100 IU/mL of recombinant human IL-2
(Kindly provided by Drs Hattori and Miyazawa) and 50M 2-
mercaptoethanol. All media and supplements were obtained from
Invitrogen Life Technologies Ltda (Paisley, United Kingdom). Cell
lines expressing CD134 and chimeric constructs were maintained
in G418 (Invitrogen, Paisley, United Kingdom). Brazilian isolates of
FIV, the subtypeB isolatesB2542 (Diehl et al., 1995) and the subtype
A isolate GL8 (Hosie and Jarrett, 1990), were tested in parallel.
2.3. Collection of peripheral blood mononuclear cells (PBMC) and
sera – virus isolation –
Blood samples were collected from 11 cats in the open shelter
that were naturally infected with FIV. The cats were displaying few
clinical signs (analogous to the asymptomatic stage of HIV infec-
tion). Sera were aliquoted and stored at −80 ◦C prior to use in
neutralization assays. PBMC were fractionated from 5mL of hep-
arinised whole blood by centrifugation using Ficoll-Paque density
separation medium (GE Healthcare, Little Chalfont, United King-
dom). The separated PBMCs were then co-cultivated with MYA-1
cells, which are highly susceptible to infection with FIV (Miyazawa
et al., 1989), without mitogenic stimulation. DNA was prepared
fromcultures identiﬁedasFIV-infectedusingcolumnchromatogra-
phy (QIAampDNAmaxiprepKit; Qiagen) as soon as FIV p24 antigen
was detected by ELISA; thus, viruses had undergone minimal pas-
sage in vitro. Eluted DNAs samples were stored at −20 ◦C.
2.4. Cloning and pseudotype virus production
The FIV envelope glycoprotein gene expression constructs
GL8 and B2542, have been described previously (Shimojima
et al., 2004; Willett et al., 2006b; Samman et al., 2010).
Full length env genes from all Brazilian isolates, replication-
competent viruses, were ampliﬁed by using the polymerase
chain reaction (PCR) using a high ﬁdelity enzyme mix (Expand
High Fidelity PCR system; Roche Diagnostics Ltda., Burgess
Hill, United Kingdom) and degenerate primers based on the
Leviano clone (FJ374697 in GenBank). The primers LevianoSal
5′-GCGTCGACAACATGGCAGAAGGAGGGTTTACTCAA-3′, and
LevianoNot 5′-GGGCGGCCGCCATCATTCCTCCTCTTTTTCAGATAT-3′
B.M. Teixeira et al. / Virus Research 160 (2011) 59–65 61
Fig. 1. Schematic of feline×humanCD134 chimeras showing the locations between
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Fig. 2. Frequency of retrovirus infections in cats from an open shelter in Brazil.he feline (gray) and human (white) regions. First and second cysteine-rich domain
re shown. Numbered arrow indicate aminoacids ﬂanking the junction.
t 0.5M and 0.2L of DNA extract were combined in reaction
ixture comprising 4L buffer, 0.2mM 2′-deoxynucleoside 5′-
riphosphates (dNTPs) (Invitrogen, Paisley, United Kingdom), 4%
v/v) DMSO (Sigma, Poole, United Kingdom), 1U PhusionTM Poly-
erase and nuclease-free water (Promega UK Ltd., Southampton,
nited Kingdom) to 20L. Ampliﬁcations were performed using
“touch down” PCR protocol consisting of an initial denaturation
t 98 ◦C for 3min, followed by 14 cycles of 98 ◦C for 10 s, 69 ◦C*
or 30 s (*decreasing by 0.5 ◦C/cycle), 72 ◦C for 2min, then a
urther 21 cycles of 98 ◦C for 10 s, 62 ◦C for 30 s, 72 ◦C for 2min,
ollowed by 72 ◦C for 10min and a ﬁnal hold at 4 ◦C. Primers were
esigned to incorporate Sal-I and Not-I restriction enzymes (sites
re underlined), the env genes were then cloned into a low-copy
umber eukaryotic expression vector, VR1012 (VICAL Inc., San
iego, CA, USA). Twelve clones from each Brazilian isolate, same
mpliﬁed DNA, were generated. These clones were named C1–C12.
IV(FIV) pseudotypes were prepared by transfecting 3.3×105
EK-293T cells with 5g of the different VR1012/env construct
ogether with 5g of pNL-Luc-E.R+ (Connor et al., 1995), an env-
eleted HIV provirus incorporating a luciferase reporter gene. The
ransfection was carried out using SuperFect® reagent – Qiagen –
ollowing the manufacturer’s instructions. Culture supernatants
ere harvested at 72h post-transfection, ﬁltered at 0.45m and
tored at −80◦ C.
.5. HIV pseudotype assays
To assess whether CD134 acts as a functional viral receptor and
o deﬁne the region of CD134 that confers functional FIV recep-
or activity, we used MCC cells (Cheney et al., 1990), that are
efractory to infection with primary strains of FIV. MCC cells had
een stably transduced with the feline CD134, human CD134, and
feline×human CD134 chimera, F(FH)H (Fig. 1) (Willett et al.,
006b). The target cell lines were seeded at 1×104 cells per well
n a CulturPlate-96 assay plate (Perkin-Elmer, Life and Analytical
ciences, Beaconsﬁeld, United Kingdom) and cultured overnight.
he cells were then infected with 50L of the each HIV(FIV)
uciferase pseudotype and cultured for 72h until luciferase activ-
ty was quantiﬁed through the addition of 50L of Steadylite
TS luciferase substrate (Perkin-Elmer) and measurements were
aken through single photon countingonaMicroBeta Luminometer
Perkin-Elmer).
.6. PCR product puriﬁcation and DNA sequencingPCRproductswerepuriﬁedusing theQIAquickgel extractionkit,
iagen. DNA was eluted in nuclease-free water and used imme-
iately or stored at −20 ◦C. Sequencing of the FIV env genes wasNumbers in parentheses indicate number of cats.
carried out using the Genetic Analyzer AB3130X (Applied Biosys-
tems) and the Big Dye Terminator v1.1 Kit (Applied Biosystems).
The reactionmixture consistedof100g/LpuriﬁedDNA,3.2pmol
of each of the primers, 4L sequencing buffer and 2L sequenc-
ing enzyme in 20L reactions. Cycling conditions were as per the
manufacturer’s protocol. Rawchromatographic datawere analysed
using ‘Contig Express’ sequence analysis softwarewithin theVector
NTI suite of programs (Invitrogen Ltda., Paisley, United Kingdom).
Chromatogram traces which appeared to contain multiple peaks
were discarded.
2.7. Phylogenetic analysis
Nucleotide sequence analysis was performed on full-length
env genes from 16 clones from Brazilian isolates included in
the study, as well as selected representative sequences from dif-
ferent subtypes. The generated consensus sequence comprised
sequences of three Brazilian isolates and reference sequences.
Multiple alignments were performed using the ClustalX (version
2.0) (Larkin et al., 2007) and BioEdit (version 7.0.9.0) applications,
followed by manual adjustment to maximize similarities. Amino
acid alignments were used as an exact guide for re-positioning of
improper gapping, particularly where sequences differed in length.
Nucleotide Maximum Likelihood (ML) tree was generated with the
GTR+ I +G substitution model and 1000 bootstrap replicates with
PAUP*4.0b10 (Swofford, 1993, 2000).
2.8. Nucleotide sequence accession numbers
The FIV sequences included in the study were as follows
(GenBank accession number, name of isolates, country and sub-
type of FIV env sequences): L00608.1, Dixon, United States, A;
L00607.1, Dixon, United States, A; M25381.1, Petaluma, United
States, A; X69496.1, UK8, England, A;M36968.1, PPR, United States,
A; D37814.1, Sendai 2, Japan, B; D37817.1, Aomori 2, Japan, B;
FJ374696, Leviano C1, Brazil, B; FJ374697, Leviano C7, Brazil, B;
FJ374695, Leviano C8, Brazil, B; AF474246.1, Canada, C; D37815.1,
Fukuoka, Japan, D; D37811.1, Shizuoka, Japan, D. All sequences
reported in this study have been deposited in GenBank.
3. Results
Five of 55 cats (9.09%) tested positive for both feline leukemia
virus (FeLV) and FIV. The seroprevalence of FIV in the open shelter
tested in this study was 50.90% (28/55), based on FIV ELISA and PCR
results. Five of these animals (5/55, 9.09%) tested positive for both
feline leukemia virus (FeLV) and FIV, and 23 (23/55, 41.82%) were
infected with FIV but were not co-infected with FeLV (Fig. 2).
We prepared 11 isolates of FIV from samples collected from
Brazilian cats. Sequence analyses demonstrated that all clones
62 B.M. Teixeira et al. / Virus Rese
Fig. 3. Phylogenetic tree of full-length viral envelope glycoprotein (env) genes from
the 16 clones from Brazilian isolates included in the study, different clones from
same ampliﬁed DNA, as well as selected representative sequences of FIV subgroups
A–D. The subtype was determined by phylogenetic analyses – Maximum Likeli-
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elonged to subtype B. Unexpectedly, little sequence variation was
bserved in circulating viruses isolated from the infected cats but,
s described previously (Teixeira et al., 2010), the sequences of
lones obtained from one cat (Didi) shown were heterogeneous.
he divergence between clone 2 and clone 10 from this cat was just
.05%. Nevertheless, this divergence was the biggest in our study. It
as notable that the majority of sequences ampliﬁed was identical
o another species within the individual cat, indicating the domi-
ance of individual variantswithin each of the quasispecies (Fig. 3).
nalysis of isolates from patients demonstrated that intra-patient
solates were more closely related than inter-patient isolates and
hat intra-patient isolates evolved over time (data not shown).
The receptorusageof eachof thevariant env cloneswas assessed
n vitro. All Brazilian isolates of FIV used CD134 as the primary
eceptor andwe tested the interactionof each strainwith the recep-
or. In contrast to the virulent primary isolate FIV-GL8, expression
f the ﬁrst cysteine-rich domain (CRD1) of feline CD134 in the con-
ext of human CD134 was sufﬁcient for optimal receptor function
or all Brazilian FIV isolates tested-ratios obtained by dividing the
uciferase activity of each pseudotype on feCD134-expressing cells
y thaton feCRD1-expressingcells. Asdescribedpreviously (Willett
t al., 2006b), F(FH)H did not support infection with the FIV-GL8
seudotype (Fig. 4).
For purposes of comparison, we examined the receptor uti-
ization from another subtype B strain of FIV, in order to discernarch 160 (2011) 59–65
whether these isolates of FIV interacted with CD134 in a similar
way. All subtype B strains tested in this study required the expres-
sion of feline CD134 CRD1 alone for infection.
4. Discussion
In our study, the prevalence of FIV was higher than that pub-
lished previously for cats in Brazil (Reche et al., 1997; Souza et al.,
2002; Caxito et al., 2006; Teixeira et al., 2007; Lara et al., 2008);
the frequency of FIV was up to 50% in the shelter cats. This result is
higher than highest seroprevalence found in sick cats in a popula-
tion sampled in Japan (Ishida et al., 1989) and should be interpreted
with caution as the samples came from just one shelter and the
cats had been feral before being placed in the shelter or were
free-roaming strays, which a consequent lack of conﬁnement and
ownership. It is knownthat theprevalenceof FIV infection is greater
in such cats. Hence the cats assessed in the study appear to be
of greater risk of infection with FIV compared to other cats and
represent an important reservoir for this retrovirus.
To characterize Brazilian FIV isolates, our study focused on the
env gene since this gene encodes the surface unit (SU) glycopro-
tein, which plays a key role in viral entry and is a target of both
humoral and cellular responses (Willett and Hosie, 2008). In most
studies, intrahost sequence variation has been assessed based on
sequence analyses of PCR amplicons obtained using DNA isolated
from the PBMC of infected cats as a template, analysing therefore
the most abundant proviral genomes rather than the full reper-
toire of virus sequences in circulation. For this reason, we cloned
all Brazilian variants detected. Our analyses demonstrated that all
clones grouped within subtype B (Fig. 3). It is important to remem-
ber that sinceneither theprevalenceof FIV infection inBrazil, nor all
prevailing subtypes are known, the determination of prevalence of
infection in cats in all Brazilian regions will be important to estab-
lish. The majority of studies have been concentrated in one area,
namely the Brazilian south-east (Martins et al., 2008; Teixeira et al.,
2010).
The existence of multiple variants (or quasispecies) of FIV has
been reported previously (Huisman et al., 2008; Teixeira et al.,
2010) as well as in this study; FIV demonstrates a relatively high
evolutionary rate, attributed largely to substitution errors made
during reverse transcription. However, there is also evidence that
viruses evolve under selection pressure to both evade the host
immune response and to achievehigher levels of replicationﬁtness.
Consequently, lentiviruses such as FIV and HIV undergo contin-
ual evolution in the host. FIV evolution during the chronic phase
of infection is potentiated by the high levels of virus replication
and the inherent error-prone nature of reverse transcription. At
any given time, as shown here, the virus population within a FIV
infected cat is heterogeneous and dynamic. Longer term monitor-
ing will be necessary to establish whether this sequence diversity
leads to a more signiﬁcant and effective population size that could
impact upon viral evolution and viral ﬁtness. It is unclear to what
extent the genetic variation of FIV that was observed in these iso-
lates was inﬂuenced by the properties of the infecting strain, the
level of replication, or the immune response to the virus.
Assays to determine receptor utilization demonstrated that,
similar to other isolates of FIV (Willett et al., 2006b), the Brazil-
ian isolates in this study used CD134 as the primary receptor in
conjunction with the chemokine co-receptor CXCR4 for infection
(Shimojima et al., 2004). Furthermore, for the Brazilian strains, the
CDR1 of fCD134 (amino acids 1–64) alone was sufﬁcient to con-
fer nearly optimal receptor function (Figs. 1 and 4). Preliminary
works have suggested that subtype B isolates are present in the
domestic cat population of Brazil (Caxito et al., 2006; Martins et al.,
2008; Teixeira et al., 2010) and an another study (Willett et al.,
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Fig. 4. Utilization of CD134 chimeras by FIV strains.MCC cells stably transducedwith a retroviral vector (pDONAI) bearing each of the chimeras, FFF and F(FH)H,were infected
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y dividing the mean (n=3) counts per minute (CPM) on feCD134-expressing cells
006b) has indicated a minimal requirement in the CRD1 of feline
D134 for the B2542 isolate, a subtype B virus that may be more
ost-adapted. Subtype B isolates appear to require a less stringent
nteractionwith the primary receptor for infection to proceed com-
ared to the pathogenic primary strains of virus, such as GL8; this
ubtype A isolate dominates in early infection and requires addi-
ional determinants on the primary receptor, included within the
econd cysteine-rich domain, CRD2, in order to form a functional
eceptor, requiring a “complex” interaction (Willett et al., 2006a,b).
t is important to remember that in the FIV infection the provirus
evels are higher in CD4+ T cells during the acute phase of infection,
hile B cells contain the majority of provirus during the chronic
hase (English et al., 1993; Dean et al., 1996). With disease pro-
ression it is possible that FIV may either lose its dependence on
inding to CD134 or interact more efﬁciently with CXCR4 (Willett
nd Hosie, 2008). Whether there is a link between the nature of
he env-CD134 interaction and the broadening of viral cell tropism
ith disease progression is a topic of on-going research. An analysis
f variants in follow-up samples from the FIV-infected cats tested
n this study would assist in this endeavour.
Although it had been suspected that the majority of FIV iso-
ates circulating within the southeastern region of Brazil belong
o subtype B, this work presents the ﬁrst evidence of genetic
iversity, based on full-length FIV env gene, in the state of São
aulo. The results of the current study, based on sequence from
6 naturally occurring isolates of FIV from São Paulo state, con-
rm that subtype B predominates (Fig. 3). The isolation, phenotype
nd envelope gene diversity of a considerable number of sam-
les of FIV from Brazil is the ﬁrst of its kind. Now experimental
nfection in animal model systems using virus stocks can facilitate
he study of determinants within the viral genome that may con-
ribute to disease pathogenesis and the development of immunity.
t is important to stress that Brazilian FIV strains have not been
ell characterized previously. Our results support a model of FIV
athogenesis whereby strains of FIV that are transmitted prefer-
ntially (“early” viruses) bind CD134 via a complex, high afﬁnity
nteractionwhereas,with disease progression, variants arise (“late”se activities were assayed at 72h postinfection and are expressed as ratios derived
CPM on feCRD1-expressing (cells).
viruses) that have a simple, reduced afﬁnity interaction through
a direct interaction with CXCR4 (Willett and Hosie, 2008). All of
the Brazilian FIV strains, examined here, are thought to repre-
sent “late” strains of FIV. Previous studies have suggested that
CD134-independent strains of FIV (for example FIV-PET) are read-
ily neutralized by antibody (Osborne et al., 1994) and thus may
be suppressed in peripheral blood, while being tolerated in priv-
ileged tissue compartments where they may disseminate more
efﬁciently. It has been suggested that subtype B isolates may be
more ancient adhost adapted and as a consequencemaybe less vir-
ulent (Bachmann et al., 1997). However, was shown recently that
long-lived hematopoietic stem cells (HSCs) can be infected by HIV
and that infection is accomplished primarily by CXCR4-tropic HIVs
(Carter et al., 2011). The conversion of HIV env from R5-tropic to
X4-tropic has been associated with more rapid disease progres-
sion, manifested as reduced CD4+ T cell counts and a poor clinical
prognosis (Connor et al., 1997; Daar et al., 2007). Future studies
will be designed to test whether strains of Brazilian FIV present in
either the early or asymptomatic phases of infection have a differ-
ent cell tropism and receptor usage compared to strains isolated
from animals displaying clinical signs.
Acknowledgements
We are grateful to Dr. Marcos Bryan Heinemann, Dr. João Pessoa
Araújo Junior and Dr. José de Melo for helpful comments on the
manuscript. Thisworkwassupported fromgrants0704180-2of the
FAPESP (the São Paulo State research funding foundation), 480330-
2007-7 of the CNPq (Brazil’s National Research Council) and Public
Heath Service grant AI049765 to B.J.W and M.J.H from the National
Institute of Allergy and Infectious Diseases.
ReferencesBachmann, M.H., Mathiason-Dubard, C., Learn, G.H., Rodrigo, A.G., Sodora, D.L.,
Mazzetti, P., Hoover, E.A., Mullins, J.I., 1997. Genetic diversity of feline immun-
odeﬁciency virus: dual infection, recombination, and distinct evolutionary rates
among envelope sequence clades. J. Virol. 71, 4241–4253.
6 s Rese
C
C
C
C
C
D
D
D
D
D
D
E
E
G
H
H
H
H
H
H
I
J
K
K
L
L
L4 B.M. Teixeira et al. / Viru
arter, C.C., McNamara, L.A., Onafuwa-Nuga, A., Shackleton, M., Riddell 4th, J., Bixby,
D., Savona, M.R., Morrison, S.J., Collins, K.L., 2011. HIV-1 utilizes the CXCR4
chemokine receptor to infect multipotent hematopoietic stem and prongenitor
cells. Cell Host Microbe 9, 23–234.
axito, F.A., Coelho, F.M., Oliveira, M.E., Resende, M., 2006. Feline immunodeﬁciency
virus subtype B in domestic cats in Minas Gerais. Braz. Vet. Res. Commun. 30,
953–956.
heney, C.M., Rojko, J.L., Kociba, G.J., Wellman, M.L., Di Bartola, S.P., Rezanka, L.J.,
Forman, L., Mathes, L.E., 1990. A feline large granular lymphoma and its derived
cell line. In Vitro Cell Dev. Biol. 26, 455–463.
onnor, R.I., Chen, B.K., Choe, S., Landau,N.R., 1995. VPR is required for efﬁcient repli-
cation of human immunodeﬁciency virus type-1 in monunuclear phagocytes.
Virology 206, 935–944.
onnor, R.I., Sheridan, K.E., Ceradini, D., Choe, S., Landau, N.R., 1997. Change in core-
ceptor use correlates with disease progression in HIV-1-infected individuals. J.
Exp. Med. 185, 621–628.
aar, E.S., Kesler, K.L., Petropoulos, C.K., Huang, W., Bates, M., Lail, A.E., Coakley,
E.P., Gomperts, E.D., Donﬁeld, S.M., HemophiliaGrowth andDevelopment Study,
2007. Baseline HIV type 1 coreceptor tropism predicts disease progression. Clin.
Infect. Dis. 45, 643–649.
e Parseval, A., Elder, J.H., 2001. Binding of recombinant feline immunodeﬁciency
virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans,
and an unidentiﬁed non-CXCR4 receptor. J. Virol. 75, 4528–4539.
e Parseval, A., Ngo, S., Sun, P., Elder, J.H., 2004a. Factors that increase the effec-
tive concentration of CXCR4 dictate feline immunodeﬁciency virus tropism and
kinetics of replication. J. Virol. 78, 9132–9143.
e Parseval, A., Chatterji, U., Sun, P., Elder, J.H., 2004b. Feline immunodeﬁciency
virus targets activated CD4+ T cells by using CD134 as a binding receptor. Proc.
Natl. Acad. Sci. U.S.A. 101, 13044–13049.
ean, G.A., Reubel, G.H., Moore, P.F., Pedersen, N.C., 1996. Proviral burden and infec-
tion kinetics of feline immunodeﬁciency virus in lymphocyte subsets of blood
and lymph node. J. Virol. 70, 5165–5169.
iehl, L.J., Mathiason-Dubard, C.K., O’neil, L.L., Hoover, E.A., 1995. Longitudi-
nal assessment of feline immunodeﬁciency virus kinetics in plasma by use
of a quantitative competitive reverse transcriptase PCR. J. Virol. 69, 2328–
2332.
nglish, R.V., Johnson, C.M., Gebhard, D.H., Tompkins,M.B., 1993. In vivo lymphocyte
tropism of feline immunodeﬁciency virus. J. Virol. 67, 5175–5186.
nglish, R.V., Nelson, P., Johnson, C.M., Nasisse, M., Tompkins, W.A., Tompkins, M.B.,
1994.Development of clinical disease in cats experimentally infectedwith feline
immunodeﬁciency virus. J. Infect. Dis. 170, 543–552.
reene, W.K., Meers, J., Del Fierro, G., Carnegie, P.R., Robinson, W.F., 1993. Extensive
sequence variation of feline immunodeﬁciency virus env genes in isolates from
naturally infected cats. Arch. Virol. 133, 51–62.
ayward, J.J., Taylor, J., Rodrigo, A.G., 2007. Phylogenetic analysis of feline immun-
odeﬁciency virus in feral and companion domestic cats of New Zealand. J. Virol.
81, 2999–3004.
ohdatsu, T., Motokawa, K., Usami, M., Amioka, M., Okada, S., Koyama, H., 1998.
Genetic subtyping and epidemiological study of feline immunodeﬁciency virus
bynestedpolymerase chain reaction-restriction fragment lengthpolymorphism
analysis of the gag gene. J. Virol. Methods 70, 107–111.
osie, M.J., Beatty, J.A., 2007. Vaccine protection against feline immunodeﬁciency
virus. Aust. Vet. J. 85, 302–303.
osie,M.J., Jarrett, O., 1990. Serological responses of cats to feline immunodeﬁciency
virus. AIDS 4, 215–220.
osie, M.J., Robertson, C., Jarrett, O., 1989. Prevalence of feline leukaemia virus and
antibodies to feline immunodeﬁciency virus in cats in the United Kingdom. Vet.
Rec. 125, 293–297.
uisman, W., Schrauwen, E.J., Rimmelzwaan, G.F., Osterhaus, A.D., 2008. Intra-
host evolution of envelope glycoprotein and OrfA sequences after experimental
infection of cats with a molecular clone and a biological isolate of feline immun-
odeﬁciency virus. Virus Res. 137, 24–32.
shida, T., Washizu, T., Toriyabe, K., Motoyoshi, S., Tomoda, I., Pedersen, N.C., 1989.
Feline immunodeﬁciency virus infection in cats of Japan. J. Am. Vet. Med. Assoc.
194, 221–225.
oshi, A., Garg, H., Tompkins, M.B., Tompkins, W.A., 2005. Preferential feline
immunodeﬁciency virus (FIV) infection of CD4+ CD25+ t-regulatory cells cor-
relates both with surface expression of CXCR4 and activation of FIV long
terminal repeat binding cellular transcriptional factors. J. Virol. 79, 4965–
4976.
akinuma, S., Motokawa, K., Hohdatsu, T., Yamamoto, J.K., Koyama, H., Hashimoto,
H., 1995. Nucleotide sequence of feline immunodeﬁciency virus: classiﬁcation
of Japanese isolates into two subtypes which are distinct from non-Japanese
subtypes. J. Virol. 69, 3639–3646.
ann, R., Seddon, J., Kyaw-Tanner, M., Meers, J., 2007. Co-infection with different
subtypes of feline immunodeﬁciency virus can complicate subtype assignment
by phylogenetic analysis. Arch. Virol. 152, 1187–1193.
ara, V.M., Taniwaki, S.A., Araujo Junior, J.P., 2008. Occurrence of feline immunode-
ﬁciency virus infection in cats. Ciênc. Rural 38, 2245–2249.
arkin, M.A., Blackshields, G., Brown, N.P., Chenna, R., Mcgettigan, P.A., Mcwilliam,
H., Valentin, F., Wallace, I.M., Wilm, A., Lopez, R., Thompson, J.D., Gibson, T.J.,
Higgins, D.G., 2007. Clustal W and clustal X version 2.0. Bioinformatics 23,
2947–2948.
ombardi, S., Bendinelli, M., Garzelli, C., 1993. Detection of B epitopes on the p24 gag
protein of feline immunodeﬁciency virus by monoclonal antibodies. AIDS Res.
Hum. Retroviruses 9, 141–146.arch 160 (2011) 59–65
Luria, B.J., Levy, J.K., Lappin, M.R., Breitschwerdt, E.B., Legendre, A.M., Hernandez,
J.A., Gorman, S.P., Lee, I.T., 2004. Prevalence of infectious diseases in feral cats in
Northern Florida. J. Feline Med. Surg. 6, 287–296.
Mallett, S., Fossum, S., Barclay, A.N., 1990. Characterization of the Mrc OX40 antigen
of activated CD4 positive t lymphocytes – a molecule related to nerve growth
factor receptor. EMBO J. 9, 1063–1068.
Martins, A.N., Medeiros, S.O., Simonetti, J.P., Schatzmayr, H.G., Tanuri, A., Brindeiro,
R.M., 2008. Phylogenetic and genetic analysis of feline immunodeﬁciency virus
gag, pol, and env genes from domestic cats undergoing nucleoside reverse tran-
scriptase inhibitor treatment or treatment-naive cats in Rio de Janeiro, Brazil. J.
Virol. 82, 7863–7874.
Mcgrath, K.M., Hoffman, N.G., Resch, W., Nelson, J.A., Swanstrom, R., 2001.
Using HIV-1 sequence variability to explore virus biology. Virus Res. 76,
137–160.
Miyazawa, T., Furuya, T., Itagaki, S., Tohya, Y., Takahashi, E., Mikami, T., 1989. Estab-
lishment of a feline t-lymphoblastoid cell line highly sensitive for replication of
feline immunodeﬁciency virus. Arch. Virol. 108, 131–135.
Olmsted, R.A., Hirsch, V.M., Purcell, R.H., Johnson, P.R., 1989. Nucleotide sequence
analysis of feline immunodeﬁciency virus: genome organization and rela-
tionship to other lentiviruses. Proc. Natl. Acad. Sci. U.S.A. 86, 8088–
8092.
Osborne, R., Rgby, M., Siebelink, K., Neil, J.C., Jarret, O., 1994. Virus neutralization
reveals antigenic variation among feline immunodeﬁciency virus isolates. J. Gen.
Virol. 75, 3641–3645.
Overbaugh, J., Bangham, C.R., 2001. Selection forces and constraints on retroviral
sequence variation. Science 292, 1106–1109.
Pancino, G., Chappey, C., Saurin, W., Sonigo, P.B., 1993a. Epitopes and selection
pressures in feline immunodeﬁciency virus envelope glycoproteins. J. Virol. 67,
664–672.
Pancino, G., Fossati, I., Chappey, C., Castelot, S., Hurtrel, B., Moraillon, A., Klatzmann,
D., Sonigo, P., 1993b. Structure and variations of feline immunodeﬁciency virus
envelope glycoproteins. Virology 192, 659–662.
Paterson, D.J., Jefferies, W.A., Green, J.R., Brandon, M.R., Corthesy, P., Puklavec,
M., Williams, A.F., 1987. Antigens of activated rat t lymphocytes including a
molecule of 50,000 mr detected only on CD4 positive t blasts. Mol. Immunol. 24,
1281–1290.
Pecoraro, M.R., Tomonaga, K., Miyazawa, T., Kawaguchi, Y., Sugita, S., Tohya, Y., Kai,
C., Etcheverrigaray,M.E.,Mikami, T., 1996.GeneticdiversityofArgentine isolates
of feline immunodeﬁciency virus. J. Gen. Virol. 77, 2031–2035.
Reche Jr., A., Hagiwara, M.K., Lucas, S.R.R., 1997. Clinical study of acquired immun-
odeﬁciency syndrome in domestic cats in São Paulo. Braz. J. Vet. Res. Anim. Sci.
34, 152–155.
Reggeti, F., Ackerley, C., Bienzle, D., 2008. CD134 and CXCR4 expression corresponds
to feline immunodeﬁciency virus infection of lymphocytes, macrophages and
dendritic cells. J. Gen. Virol. 89, 277–287.
Reggeti, F., Bienzle, D., 2004. Feline immunodeﬁciency virus subtypes A, B and
C and intersubtype recombinants in Ontario, Canada. J. Gen. Virol. 85, 1843–
1852.
Roberts, J.D., Bebenek, K., Kunkel, T.A., 1988. The accuracy of reverse transcriptase
from HIV-1. Science 242, 1171–1173.
Samman, A., Logan, N., Mcmonagle, E.L., Ishida, T., Mochizuki, M., Willett, B.J., Hosie,
M.J., 2010. Neutralization of feline immunodeﬁciency virus by antibodies tar-
geting the V5 loop of env. J. Gen. Virol. 91, 242–249.
Swofford, D.L., 1993. Paup-a computer-program for phylogenetic inference using
maximum parsimony. J. Gen. Physiol. 102, A9.
Swofford, D.L., 2000. Phylogenetic Analysis using Parsimony (* and Other Methods),
fourth ed. Sunderland, Massachesetts.
Shimojima, M., Miyazawa, T., Ikeda, Y., Mcmonagle, E.L., Haining, H., Akashi, H.,
Takeuchi, Y., Hosie, M.J., Willett, B.J., 2004. Use of CD134 as a primary receptor
by the feline immunodeﬁciency virus. Science 303, 1192–1195.
Siebelink, K.H., Chu, I.H., Rimmelzwaan, G.F., Weijer, K., Osterhaus, A.D., Bosch, M.L.,
1992. Isolation and partial characterization of infectious molecular clones of
feline immunodeﬁciency virus obtained directly from bone marrow DNA of a
naturally infected cat. J. Virol. 66, 1091–1097.
Sodora, D.L., Shpaer, E.G., Kitchell, B.E., Dow, S.W., Hoover, E.A., Mullins, J.I., 1994.
Identiﬁcation of three feline immunodeﬁciency virus (FIV) env gene subtypes
and comparison of the FIV and human immunodeﬁciency virus type 1 evolu-
tionary patterns. J. Virol. 68, 2230–2238.
Souza, H.J.M., Teixeira, C.H.R., Grac¸a, R.F.S., 2002. Epidemiological study of feline
leukaemia virus and feline immunodeﬁciency virus infections in domestic cats
in the city of Rio de Janeiro. Clín. Vet. 36, 14–21.
Talbott, R.L., Sparger, E.E., Lovelace, K.M., Fitch, W.M., Pedersen, N.C., Luciw, P.A.,
Elder, J.H., 1989. Nucleotide sequence and genomic organization of feline
immunodeﬁciency virus. Proc. Natl Acad. Sci. U.S.A. 86, 5743–5747.
Teixeira, B.M., Logan, N., Cruz, J.C., Reis, J.K., Brandao, P.E., Richtzenhain, L.J., Hagi-
wara, M.K., Willett, B.J., Hosie, M.J., 2010. Genetic diversity of Brazilian isolates
of feline immunodeﬁciency virus. Arch. Virol. 155, 379–384.
Teixeira, B.M., Rajão, D.S., Haddad, J.P.A., Leite, R.C., Reis, J.K.P., 2007. Occurrence of
feline immunodeﬁciency virus and feline leukemia virus in sheltered domestic
cats of Belo Horizonte. Arq. Bras. Med. Vet. Zoot. 59, 939–942.
Weaver, E.A., Collisson, E.W., Slater, M., Zhu, G., 2004. Phylogenetic analyses of texas
isolates indicate an evolving subtype of the clade B feline immunodeﬁciency
viruses. J. Virol. 78, 2158–2163.
Willett, B.J., Hosie, M.J., 2008. Chemokine receptors and co-stimulatory
molecules: unravelling feline immunodeﬁciency virus infection. Vet. Immunol.
Immunopathol. 123, 56–64.
s Rese
W
WB.M. Teixeira et al. / Viru
illett, B.J., Kraase, M., Logan, N., Mcmonagle, E.L., Samman, A., Hosie, M.J., 2010.
Modulation of the virus-receptor interaction by mutations in the V5 loop of
feline immunodeﬁciency virus (FIV) following in vivo escape from neutralising
antibody. Retrovirology 7, 38.
illett, B.J., Mcmonagle, E.L., Bonci, F., Pistello, M., Hosie, M.J., 2006a. Mapping the
domains of CD134 as a functional receptor for feline immunodeﬁciency virus. J.
Virol. 80, 7744–7747.arch 160 (2011) 59–65 65
Willett, B.J., Mcmonagle, E.L., Ridha, S., Hosie, M.J., 2006b. Differential utilization of
CD134 as a functional receptor by diverse strains of feline immunodeﬁciency
virus. J. Virol. 80, 3386–3394.
Yamamoto, J.K., Hansen,H.,Ho, E.W.,Morishita, T.Y., Okuda, T., Sawa, T.R., Nakamura,
R.M., Pedersen, N.C., 1989. Epidemiologic and clinical aspects of feline immun-
odeﬁciency virus infection in cats from the continentalUnited States andCanada
and possible mode of transmission. J. Am. Vet. Med. Assoc. 194, 213–220.
